Common FDA-approved drug may neutralize COVID virus

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

SARS-CoV-2, the virus that causes COVID-19, uses a surface spike protein to latch onto human cells and initiate infection. But heparin, a blood thinner also available in non-anticoagulant varieties, binds tightly with the surface spike protein, potentially blocking the infection from happening. This makes it a decoy, which might be introduced into the body using a nasal spray or nebulizer and run interference to lower the odds of infection. Similar decoy strategies have already shown promise in curbing other viruses, including influenza A, Zika, and dengue.

“This approach could be used as an early intervention to reduce the infection among people who have tested positive, but aren’t yet suffering symptoms. But we also see this as part of a larger antiviral strategy,” said Robert Linhardt, lead author and a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute. “Ultimately, we want a vaccine, but there are many ways to combat a virus, and as we’ve seen with HIV, with the right combination of therapies, we can control the disease until a vaccine is found.”…

https://www.sciencedaily.com/releases/2020/07/200715123203.htm

Vitamins D, C, glutathione, NAC, hydroxychloroquine + zinc, inhaled steroids, inhaled colloidal silver, melatonin and now apparently heparin are all cheap, safe and effective treatments or preventions for covid-19.    But when do we get our ultra-expensive, untested, dangerous, likely-ineffective and liability-immune vaccine?   Probably not until after the entire country is a vast company town.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.